1. Home
  2. GLYC vs JFU Comparison

GLYC vs JFU Comparison

Compare GLYC & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLYC
  • JFU
  • Stock Information
  • Founded
  • GLYC 2003
  • JFU 2006
  • Country
  • GLYC United States
  • JFU China
  • Employees
  • GLYC N/A
  • JFU N/A
  • Industry
  • GLYC Biotechnology: Pharmaceutical Preparations
  • JFU Finance: Consumer Services
  • Sector
  • GLYC Health Care
  • JFU Finance
  • Exchange
  • GLYC Nasdaq
  • JFU Nasdaq
  • Market Cap
  • GLYC 15.9M
  • JFU 17.8M
  • IPO Year
  • GLYC 2014
  • JFU 2019
  • Fundamental
  • Price
  • GLYC $0.19
  • JFU $1.35
  • Analyst Decision
  • GLYC Hold
  • JFU
  • Analyst Count
  • GLYC 3
  • JFU 0
  • Target Price
  • GLYC N/A
  • JFU N/A
  • AVG Volume (30 Days)
  • GLYC 228.8K
  • JFU 4.7K
  • Earning Date
  • GLYC 05-08-2025
  • JFU 01-01-0001
  • Dividend Yield
  • GLYC N/A
  • JFU N/A
  • EPS Growth
  • GLYC N/A
  • JFU N/A
  • EPS
  • GLYC N/A
  • JFU 0.09
  • Revenue
  • GLYC N/A
  • JFU $40,614,155.00
  • Revenue This Year
  • GLYC N/A
  • JFU N/A
  • Revenue Next Year
  • GLYC N/A
  • JFU N/A
  • P/E Ratio
  • GLYC N/A
  • JFU $15.56
  • Revenue Growth
  • GLYC N/A
  • JFU N/A
  • 52 Week Low
  • GLYC $0.14
  • JFU $1.13
  • 52 Week High
  • GLYC $3.02
  • JFU $3.75
  • Technical
  • Relative Strength Index (RSI)
  • GLYC 31.68
  • JFU 46.12
  • Support Level
  • GLYC $0.19
  • JFU $1.26
  • Resistance Level
  • GLYC $0.22
  • JFU $1.48
  • Average True Range (ATR)
  • GLYC 0.02
  • JFU 0.11
  • MACD
  • GLYC -0.01
  • JFU -0.01
  • Stochastic Oscillator
  • GLYC 16.67
  • JFU 36.36

About GLYC GlycoMimetics Inc.

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

About JFU 9F Inc.

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.

Share on Social Networks: